Craven P A, DeRubertis F R
Department of Medicine, VA Medical Center, Pittsburgh, Pennsylvania.
Cancer Res. 1992 Apr 15;52(8):2216-21.
Protein kinase C activity and the profile of protein kinase C isozymes alpha, beta, and gamma were examined in subcellular fractions of 1,2-dimethylhydrazine induced colonic adenocarcinomas, surrounding uninvolved colonic mucosa and colonic mucosa from age matched control rats. Responsiveness of colonic mucosal protein kinase C to phorbol dibutyrate induced translocation of the enzyme from the soluble to the particulate cell fraction was also assessed. Although total protein kinase C and specific activities of soluble and particulate enzymes were higher in colonic mucosa of carcinogen treated rats which developed tumors than corresponding values of control mucosa, the subcellular distribution of enzyme activity was not different between uninvolved colonic mucosa of 1,2-dimethylhydrazine treated rats and colonic mucosa of age matched control rats. Thus, evidence for activation of the protein kinase C system of mucosa of the carcinogen treated rats was lacking. Exposure of colonic mucosa from control rats to phorbol dibutyrate induced a clear translocation of enzyme activity from the soluble to the particulate fraction. By contrast, no change in subcellular distribution of protein kinase C activity was noted on exposure of colonic mucosa from 1,2-dimethylhydrazine treated rats to phorbol dibutyrate. Immunoblotting of subcellular fractions of colonic mucosa from control and 1,2-dimethylhydrazine treated rats demonstrated the presence of protein kinase C alpha, but no detectable beta and gamma forms. Total protein kinase C activity and the specific activity of protein kinase C in soluble and particulate fractions was significantly lower in adenocarcinomas compared to uninvolved surrounding mucosa. In contrast to results obtained with colonic mucosa from control and 1,2-dimethylhydrazine treated rats, adenocarcinomas expressed predominantly the beta form of protein kinase C. The alpha form represented less than 10% of the total detectable immunoreactivity in adenocarcinomas. The alterations in protein kinase C isoenzyme expression in tumors and loss of responsiveness of premalignant mucosa to phorbol dibutyrate may be involved in the process of malignant transformation.
研究了1,2 - 二甲基肼诱导的结肠腺癌、周围未受累结肠黏膜以及年龄匹配对照大鼠的结肠黏膜亚细胞组分中的蛋白激酶C活性以及蛋白激酶C同工酶α、β和γ的分布情况。还评估了结肠黏膜蛋白激酶C对佛波酯二丁酯诱导的该酶从可溶性细胞组分向颗粒性细胞组分转位的反应性。虽然发生肿瘤的致癌物处理大鼠的结肠黏膜中总蛋白激酶C以及可溶性和颗粒性酶的比活性高于对照黏膜的相应值,但1,2 - 二甲基肼处理大鼠未受累结肠黏膜与年龄匹配对照大鼠的结肠黏膜之间酶活性的亚细胞分布并无差异。因此,缺乏致癌物处理大鼠黏膜中蛋白激酶C系统激活的证据。对照大鼠的结肠黏膜暴露于佛波酯二丁酯会诱导酶活性从可溶性组分向颗粒性组分的明显转位。相比之下,1,2 - 二甲基肼处理大鼠的结肠黏膜暴露于佛波酯二丁酯后,蛋白激酶C活性的亚细胞分布未观察到变化。对对照和1,2 - 二甲基肼处理大鼠的结肠黏膜亚细胞组分进行免疫印迹分析显示存在蛋白激酶Cα,但未检测到β和γ形式。与周围未受累黏膜相比,腺癌中总蛋白激酶C活性以及可溶性和颗粒性组分中蛋白激酶C的比活性显著降低。与对照和1,2 - 二甲基肼处理大鼠的结肠黏膜结果不同,腺癌主要表达蛋白激酶C的β形式。α形式在腺癌中占总可检测免疫反应性的不到10%。肿瘤中蛋白激酶C同工酶表达的改变以及癌前黏膜对佛波酯二丁酯反应性的丧失可能参与了恶性转化过程。